Page 46 - MDAnderson Memoria 2018
P. 46

Listado de ensayos clínicos iniciados en 2017
List of clinical trials started in 2017
  Randomized, Multicenter, Open-Label, Phase 3 Study of Acalabrutinib (ACP-196) Versus Investigator’s Choice of Either Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia
  Dra. Raquel de Oña
 A phase I/II, open-label, 2 arm study to investigate the safety, clinical activity, pharmacokinetics and pharmacodynamics of GSK2879552 administered alone or in combination with azacitidine, in adult subjects with IPSS-R high, and very high risk myelodysplastic syndromes (MDS) previously treated with hypomethylating agents (HMA)
 Dr. Adolfo de la Fuente
 2013-0609 (MOONSHOT)
MD Anderson Houston
Validación de biomarcadores para la detección precoz del cáncer de pulmón en una cohorte que participa en un programa de cribado por TAC helicoidal de dosis bajas. Moonshot Programs MD Anderson Cancer Houston
Validation of biomarkers for the early detection of lung cancer in a cohort participating in a low-dose helical CT scan screening program. MD Anderson Cancer Center Houston Moonshot Programs
Dra. Natalia Carballo
  Pattern of use and safety/effectiveness of nivolumab in routine oncology practice
  Dra. Pilar López Criado
 E011-MEL (eTheRNA)
eTheRNA Inmunoterapies
A phase I open label study to assess the safety and tolerability of ECI-006 mRNA immunotherapy administered intranodally to patients with stages IIc/III/IV melanoma following surgical resection and with no evidence of disease
Dra. Pilar López Criado
  An Open-label, Multicenter Phase 1a/2a Trial Investigating the Safety, Tolerability and Antitumor Activity of Multiple Doses of Sym015, a Monoclonal Antibody Mixture Targeting MET, in Patients with Advanced Solid Tumor Malignancies
  Dra. Pilar López Criado
  El listado completo de los ensayos clínicos que se llevan a cabo en la Fundación MD Anderson Cancer Center España está disponible en el siguiente enlace:
The complete list of clinical trials carried out at MD Anderson Cancer Center Foundation Spain is available on the following link:

   44   45   46   47   48